Steba Biotech logo - Photodynamic Therapy photodynamic therapy for Prostate Cancer, header photodynamic therapy for prostate cancer, header
current homeprostate cancerphotodynamic theraphycurrent studiesresourcescontacts
Photodynamic Therapy - Steba Biotech

Current studies in UK

What studies are currently being carried out using vascular targeted PDT for prostate cancer in the UK?

At present there is one study using vascular targeted PDT for prostate cancer in UK. It is being run at University College London Hospitals Trust. The urologist in charge of the study is Mr Mark Emberton.

Can I take part in this study?

This study is suitable for men who:
  • Have prostate cancer confined to the prostate (localised disease – see prostate cancer section for further details)
  • Do not wish to have curative treatment at present, or are currently having active surveillance
  • Have not had any surgery on the prostate, including treatment for benign prostate enlargement
  • Are reasonably healthy, and do not have heart disease, in particular, are able to travel to University College London Hospital for study tests, treatment and follow up

If you want to be considered for the study, either your GP or your urologist will need to refer you to:
Mr Mark Emberton,
Senior Lecturer and Honorary Consultant in Urological Oncology,
The Middlesex Hospital, Mortimer Street, London W1.


Copyright © 2005-2007 STEBA Biotech N.V.  Disclaimer  Glossary of terms

UCL PDT staff
UCL logo

spacer spacer spacer